ESR1 and obesity due to melanocortin 4 receptor deficiency: Therefore, we believe that further study of TRIM28 modulation of ER α and PR activity will provide the insight towards developing non-hormonal therapy for endometrial diseases and, more importantly, multiple systematic diseases including the immune disturbances, muscular hypotrophy and obesity that have been linked to TRIM28 deletion11–13.